Correvio Pharma Corp. Long-Term Debt, Maturity, Year One
Correvio Pharma Corp. had Long-Term Debt, Maturity, Year One of $17.83 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2020-04-30
- 2019-12-31: Long-Term Debt, Maturity, Year One $17.83M.
- 2018-12-31: Long-Term Debt, Maturity, Year One $0.00.
- 2017-12-31: Long-Term Debt, Maturity, Year One $0.00.
- 2016-12-31: Long-Term Debt, Maturity, Year One $0.00.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2019-12-31 | $17.83M 20-F · filed 2020-04-30 |
| 2018-12-31 | $0.00 40-F · filed 2019-03-13 |
| 2017-12-31 | $0.00 20-F · filed 2018-04-30 |
| 2016-12-31 | $0.00 40-F · filed 2017-03-29 |
| 2015-12-31 | $4.00M 40-F · filed 2016-03-29 |
| 2014-12-31 | $1.71M 40-F · filed 2015-03-27 |